Prescription Sleep Medication Evidence Base
Large randomized trials show clear, replicated efficacy for prescription hypnotics.
- 2,000+: RCTs analyzed (across decades of research)
- ~500: Median trial size (patients per study)
- Large: Effect vs placebo (consistent across trials)
- High: GRADE evidence quality (well-characterized profile)
Randomized controlled trial density
Thousands of RCTs support benzodiazepine and Z-drug efficacy.
Meta-analytic consistency
Meta-analyses consistently confirm reduced sleep latency and awakenings.
Known safety and risk profile
Dependence and side-effect risks are well documented and quantified.
Valerian Root Clinical Trial Evidence
Small, heterogeneous trials show modest, inconsistent effects on sleep onset.
- ~60: Trials analyzed (small RCTs)
- ~30: Median trial size (patients per study)
- Small: Effect vs placebo (inconsistent across studies)
- Low: GRADE evidence quality (heterogeneous methods)
Small sample sizes
Most valerian trials enroll fewer than fifty participants.
Mixed methodological quality
Blinding and dosing standardization vary widely across studies.
Inconsistent outcome measures
Sleep latency improvements appear in some trials, not others.
Glycine Amino Acid Sleep Research
Limited trials suggest modest gains in subjective sleep quality.
- ~10: Trials analyzed (small RCTs)
- ~20: Median trial size (patients per study)
- Modest: Effect vs placebo (mostly subjective)
- Very low: GRADE evidence quality (preliminary findings)
Small pilot trials
Most glycine studies are brief, single-site pilot experiments.
Subjective quality over objective latency
Improvements appear in self-reported freshness, less in objective latency.
Mechanistic plausibility, limited confirmation
Animal data outpaces human confirmation of the sleep mechanism.
Comparing Evidence Strength Across Options
Herbal options show weaker, less consistent evidence than prescription drugs.
- 82/100: Prescription quality (evidence quality score)
- 38/100: Valerian quality (evidence quality score)
- 42/100: Glycine quality (evidence quality score)
- ~30:1: Trial count ratio (prescription-to-herbal)
Sample size gap
Prescription trials enroll far more patients than herbal studies.
Consistency across replications
Prescription effects replicate reliably; herbal effects vary by study.
Publication and funding bias
Herbal research suffers smaller budgets and selective publication.
Matching Evidence to Patient Needs
Herbal aids may suit mild cases; prescriptions suit severe insomnia.
- Herbal OK: Mild insomnia (reasonable first try)
- Rx preferred: Moderate insomnia (stronger support needed)
- Rx strongly: Severe insomnia (best-supported option)
- Always: Shared decision-making (recommended in practice)
Mild, situational sleep trouble
Valerian or glycine may help mild, occasional sleep difficulty.
Moderate to severe insomnia
Prescription options offer stronger, better-supported relief for significant insomnia.
Individualized, evidence-informed choice
Severity and evidence strength together should guide treatment choice.